Animal Drug Compounding Market to Reach US$ 2.4 Bn by 2031, TMR Study
13 Dec 2022
Radiation Therapy
Demand for compounding medication for personalized medical care of exotic companion animal's fuels growth in animal drug compounding market
Rapid adoption of newer therapies to propel North America market, Asia Pacific to record high growth rate over the forecast period
WILMINGTON, Del., Dec. 13, 2022
/PRNewswire/ -- According to a recent market intelligence report by TMR, the global animal drug compounding market is estimated to register a CAGR of 7.4% over the forecast period of 2022 to 2031. Increase in the global population of companion, as well as exotic pet animals is driving the market growth. Furthermore, rising demand for personalized and at times customizable medications for these companion animals is creating worthwhile opportunities for the players operating in the animal drug compounding market. Rising approval for these new and innovative drug compounding practices by animal owners is also boosting demand within the market.
Get Exclusive PDF Sample Copy of
Animal Drug Compounding Market
– https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50493
Animal Drug Compounding Market – Key Findings of the Report
Growing Number of Companion Animals: Increase in the number of companion animals is one of the most prominent drivers for the market growth. Cats and dogs being two of the most common types of companion animals found in households across the world, manufacturers in the market are focusing on increasing their research and development efforts to facilitate new and innovative product launches.
Rising Demand for Anti-Infective Drugs: Anti-infective drugs, consisting of anti-bacterial drugs, anti-fungal drugs, antiphrastic drugs, and anti-viral drugs, account for the largest demand in the market. Most commonly used to treat or prevent animals from minor infections, these drugs are also useful in treating serious infectious diseases, such as tuberculosis or pneumonia.
Animal Drug Compounding Market – Growth Drivers
Surge in the number of licensed pharmacists and veterinarians propel growth within the global animal drug compounding market
Rising number of pet owners trigger an increase in the number of animal drug compounding pharmacies
Animal drug compounding industry size grows on the back of rising demand for companion and support animals
Animal Drug Compounding Market – Key Players
Owing to a small number of prominent players and manufacturers operational in the industry, the competitive landscape of this market is consolidated in nature. Some of the leading companies functioning in the global animal drug compounding market include Triangle Compounding Pharmacy, Custom Med Compounding Pharmacy, Wellness Pharmacy of Cary, Millers Pharmacy, Specialist Compounding Pharmacy Pte Ltd., Wedgewood Pharmacy, Davis Islands Pharmacy, Caringbah Compounding Pharmacy, Smith's Pharmacy, Tache Pharmacy, and Central Compounding Center South. To gain an advantage over their competitors, various players operating animal compounding pharmacy facilities employ strategic tactics, such as alliances with other players, mergers and acquisitions, and product innovation as well as inventory expansion. Furthermore, certain leading industry players are also undertaking collaborations and partnerships to enhance their presence and attract a larger customer base.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=50493
Animal Drug Compounding Market: Regional Growth Assessment
In 2021, North America dominated the global animal drug compounding market. Growth in the number of animal medicine compounding pharmacy facilities in the North America region is one of the most significant drivers for the expansion of this regional market. Some other salient drivers for growth of the North America market include the presence of robust healthcare infrastructure for both humans and animals, as well as the early adoption of new and innovative therapeutic procedures and strategies by veterinarians and animal healthcare specialists in the region.
On the other hand, the Asia Pacific region is anticipated to record the highest growth in the global market in coming years. This trend can be attributed to increasing consumer acceptance of different types of compounded veterinary preparation and planning, as well as growth in the number of pet owners. Rising availability and consumer preference for customized preparations of compounded drugs is also anticipated to bolster growth in both Asia Pacific and North America regional markets over the forecast period.
Animal Drug Compounding Market: Segmentation
Animal Drug Compounding Market, by Product
Ketaconazole
Others
Anti-inflammatory
Prednisolone
Others
Potassium Bromide
Other CNS Agents
Other GI Drugs
Others
Others
Quick Delivery Available | Buy this Premium Research Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=50493<ype=S
Animal Drug Compounding Market, by Animal Type
Companion Animal
Dogs
Cats
Others
Livestock
Animal Drug Compounding Market, by Dosage Form
Capsules
Solutions
Powders
Suspension
Others
Animal Drug Compounding Market, by Route of Administration
Oral
Topical
Rectal
Ocular
Animal Drug Compounding Market, by Region
North America
Europe
Latin America
Middle East and Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Primary Progressive Multiple Sclerosis Treatment Market: Primary Progressive Multiple Sclerosis Treatment Market is expected to exceed US$ 3.2 Bn by the end of 2031, growing at a CAGR of 14.7% from 2022 to 2031.
Fusion Inhibitors Market: FusionFusion Inhibitors Market is projected to advance at a CAGR of 14.2% from 2022 to 2031 and reach more than US$ 7.2 Bn by 2031.
Rare Kidney Diseases Treatment Market: Rare Kidney Diseases Treatment Market is projected to grow at a CAGR of 5.8% from 2022 to 2031 and reach more than US$ 4.6 Bn by the end of 2031.
Anti-radiation Drugs Market: Anti-radiation Drugs Market is projected to grow at a CAGR of 9.9% from 2022 to 2031 to reach more than US$ 9.6 Bn by the end of 2031.
Halal and Kosher Empty Capsules Market: Halal and Kosher Empty Capsules Market is projected to grow at a CAGR of 8.0% from 2022 to 2031 and reach more than US$ 2.9 Bn by the end of 2031.
Alzheimer's Disease Biomarkers Market: Alzheimer's Disease Biomarkers Market is anticipated to grow at a CAGR of 7.3% from 2022 to 2031 and reach more than US$ 1.7 Bn by the end of 2031.
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact :
Nikhil Sawlani
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
SOURCE Transparency Market Research
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.